Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process."

Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.

NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:

• Whole genome sequencing
• Targeted/amplicon resequencing
• Exome sequencing
• SNP analysis
• RNA sequencing
• Gene expression profiling
• Transcriptomics
• Small RNA/miRNA analysis
• ChIP-seq
• Methylation analysis
• Metagenomics

Worldwide Sequencer Market, 2023-2028 provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.